Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.
FDA grants priority review for Novartis’ leukaemia treatment
Novartis’ ASC4FIRST study enrolled 405 adult patients. Credit: Melnikov Dmitriy / Shutterstock. The US Food and Drug Administration (FDA) has granted priority review designation for